Cultural primer for cardiometabolic health: health disparities, structural factors, community, pathways to improvement, and clinical applications

References

• U.S. Department of Health and Human Services. The Secretary’s Advisory Committee on National Health Promotion and Disease Prevention Objectives for 2020. Phase I report: Recommendations for the framework and format of Healthy People 2020 [Internet]. Section IV: Advisory Committee findings and recommendations [cited 2017 Oct 6]. Available from: http://www.healthypeople.gov/sites/default/files/PhaseI_0.pdf
   Google Scholar
• Galobardes B, Lynch J, Smith GD. Measuring socioeconomic position in health research. Br Med Bull. 2007;81-82:21–37.
   PubMed Web of Science ®Google Scholar
• Havranek EP, Mujahid MS, Barr DA, et al. American Heart Association Council on Quality of Care and Outcomes Research, Council on Epidemiology and Prevention, Council on Cardiovascular and Stroke Nursing, Council on Lifestyle and Cardiometabolic Health, and Stroke Council. Social determinants of risk and outcomes for cardiovascular disease: a scientific statement from the American Heart Association. Circulation. 2015;132(8):873–898.
   PubMedGoogle Scholar
• Mayberry RM, Nicewander DA, Qin H, et al. Improving quality and reducing inequities: a challenge in achieving best care. Proc (Bayl Univ Med Cent). 2006;19(2):103–118.
   PubMedGoogle Scholar
• Powell A The costs of inequality: money = quality health care = longer life. Harvard Gazette. 2016 Feb 22 [cited 2017 Oct 11]. Available from: https://news.harvard.edu/gazette/story/2016/02/money-quality-health-care-longer-life/
   Google Scholar
• Heiman HJ, Artiga S. Beyond health care: the role of social determinants in promoting health and health equity. Menlo Park (CA): Kaiser Family Foundation. 2015 [cited 2017 Oct 11]. Available from: http://www.kff.org/disparities-policy/issue-brief/beyond-health-care-the-role-of-social-determinants-in-promoting-health-and-health-equity/
   Google Scholar
• Wilkinson R, Marmot M, editors. Social determinants of health: the solid facts. 2nd ed. Copenhagen, Denmark: World Health Organization Europe, International Centre for Health & Society; 2003.
   Google Scholar
• Campbell IM. A multilevel nursing research model for health disparity reduction and cultural competency intervention. Hisp Health Care Int. 2005;3(1):3–7.
   Google Scholar
• Angel JL, Angel RJ. Minority group status and healthful aging: social structure still matters. Am J Public Health. 2006;96(7):):1152–1159.
   PubMed Web of Science ®Google Scholar
• Levi J, Segal L, St. Laurent R, et al. The state of obesity. Better policies for a healthier America. Racial and ethnic disparities in obesity. Princeton (NJ): Robert Wood Johnson Foundation, Trust for America’s Health; 2014 Sep [cited 2017 Oct 14]. Available from: http://stateofobesity.org/disparities/
   Google Scholar
• Woolf SH. Progress in achieving health equity requires attention to root causes. Health Aff (Millwood). 2017;36(6):984–991.
   PubMed Web of Science ®Google Scholar
• 2016 National Healthcare Quality & Disparities Report. Rockville (MD): Agency for Healthcare Research and Quality; 2017Jul. AHRQ Pub. No. 17-0001. [cited 2017 Sep 24]. Available from: https://www.ahrq.gov/research/findings/nhqrdr/nhqdr16/index.html
   Google Scholar
• Kilbourne AM, Switzer G, Kelly Hyman K, et al. Advancing health disparities research within the health care system: a conceptual framework. Am J Public Health. 2006;96(12):2113–2121.
   PubMed Web of Science ®Google Scholar
• McGovern L, Miller G, Hugher-Cromwick P “Health policy brief: the relative contribution of multiple determinants to health outcomes.” Health Affairs, 2014 Aug 21. [cited 2017 Oct 14]. Available from: http://www.healthaffairs.org/healthpolicybriefs/brief.php?brief_id=123
   Google Scholar
• Gee GC, Payne-Sturges DC. Environmental health disparities: a framework integrating psychosocial and environmental concepts. Environ Health Perspect. 2004;112:1645–1653.
   PubMed Web of Science ®Google Scholar
• World Health Organization. The World Health Report 2002: reducing risks, promoting healthy life. Geneva: World Health Organization; 2002.
   Google Scholar
• Friel S, Marmot MG. Action on the social determinants of health and health inequities goes global. Annu Rev Public Health. 2011;32:225–236.
   PubMed Web of Science ®Google Scholar
• Davis RS, Harding SM, Macaysa A, et al. Countering the production of inequities: an emerging systems framework to achieve an equitable culture of health. Oakland (CA): The Prevention Institute; 2016; 2016. [cited 2017 Oct14]. Available from: http://media.wix.com/ugd/b49d47_3c56f7659645462b8b8962299deb9bd9.pdf
   Google Scholar
• Social Determinants Of Health. Healthy People 2020. HealthyPeople.gov. Rockville (MD): Office of Disease Prevention and Health Promotion;; 2017. [cited 2017 Oct 14]. Available from: https://www.healthypeople.gov/2020/topics-objectives/topic/social-determinants-of-health
   Google Scholar
• Program Planning. Health People 2020. HealthyPeople.gov. Rockville (MD): Office of Disease Prevention and Health Promotion; 2017. [cited 2017 Oct 14]. Available from: https://www.healthypeople.gov/2020/tools-and-resources/Program-Planning
   Google Scholar
• Ahnquist J, Wamala SP, Lindstrom M. Social determinants of health–a question of social or economic capital? Interaction effects of socioeconomic factors on health outcomes. Soc Sci Med. 2012;74(6):930–939.
   PubMed Web of Science ®Google Scholar
• Institute of Medicine (US) Committee on Quality of Health Care in America. Crossing the quality chasm. a new health system for the 21st century. Washington (DC): National Academies Press (US); 2001.
   Google Scholar
• Communities in action: pathways to health equity. National Academies of Sciences, Engineering, and Medicine, Health and Medicine Division, Board on Population Health and Public Health Practice. In: Baciu A, Negussie Y, Geller A, et al., editors. Committee on community-based solutions to promote health equity in the United States. Washington (DC): National Academies Press; 2017.
   Google Scholar
• Farrer L, Marinetti C, Cavaco YK, et al. Advocacy for health equity: a synthesis review. Milbank Q. 2015;93(2):392–437.
   PubMed Web of Science ®Google Scholar
• Robert Wood Johnson Foundation (RWJF). How we work building a culture of health. Princeton (NJ); 2017 [cited Oct 14]. Available from: http://www.rwjf.org/en/how-we-work/building-a-culture-of-health.html
   Google Scholar
• Centers for Disease Control and Prevention. Policy evidence assessment report: community health worker policy components. Atlanta (GA): U.S. Department of Health and Human Services, Centers for Disease Control and Prevention; 2014 [cited 2017 Oct 11]. Available from: http://www.cdc.gov/dhdsp/pubs/docs/chw_evidence_assessment_report.pdf
   Google Scholar
• Centers for Disease Control and Prevention (CDC). CDC community health improvement navigator. Atlanta (GA): CDC; 2016 [cited 2017 Oct 2]. Available from: http://www.cdc.gov/chinav/
   Google Scholar
• Community Tool Box. Chapter 1. Section 7. Working together for healthier communities: a framework for collaboration among community partnership, support organizations, and funders. Work Group for Community Health and Development. Lawrence (KS): University of Kansas; 2016 [cited 2017 Oct 11]. Available from: http://ctb.ku.edu/en/table-of-contents/overview/model-for-community-change-and-improvement/framework-for-collaboration/main
   Google Scholar
• Chang WC, Fraser JH. Cooperate! A paradigm shift for health equity. Int J Equity Health. 2017;16:12.
   PubMed Web of Science ®Google Scholar
• American Hospital Association. Equity of care: a toolkit for eliminating health care disparities. [cited 2017 Oct 11]. Available from: http://www.hpoe.org/Reports-HPOE/equity-of-care-toolkit.pdf
   Google Scholar
• Institute of Medicine. The future of the public’s health in the 21st century. Washington (DC): The National Academies Press; 2003 [cited 2017 Oct 12]. Available from: https://doi.org/10.17226/10548
   Google Scholar
• Schroeder SA. Shattuck Lecture. We can do better–improving the health of the American people. N Engl J Med. 2007;357(12):1221–1228.
   PubMed Web of Science ®Google Scholar
• Braveman P, Gottlieb L. The social determinants of health: it’s time to consider the causes of the causes. Public Health Rep. 2014;129(Suppl 2)):19–31.
   PubMed Web of Science ®Google Scholar
• What Works for Health. In County Health Rankings & Roadmaps. University of Wisconsin Population Health Institute. Madison (WI); 2017. [cited 2017 Oct 15]. Available from: http://www.countyhealthrankings.org/roadmaps/what-works-for-health
   Google Scholar
• Healthy lives for people in the UK. London (UK): The Health Foundations; 2017. [cited 2017 Oct 15]. Available from: http://www.health.org.uk/publication/healthy-lives-people-uk
   Google Scholar
• World Health Organization. A conceptual framework for action on the social determinants of health. Geneva: WHO International; 2010 [cited 2017 Oct 14]. Available from: www.who.int/sdhconference/resources/ConceptualframeworkforactiononSDH_eng.pdf
   Google Scholar
• World Health Organization. Closing the gap in a generation: health equity through action on the social determinants of health. Final report of the Commission on Social Determinants of Health. Geneva: WHO International; 2008 [cited 2017 Oct 14]. Available from: http://www.who.int/social_determinants/final_report/en/
   Google Scholar
• National Prevention Council. National prevention strategy. Washington (DC): U.S. Department of Health and Human Services, Office of the Surgeon General; 2011 [cited 2017 Oct 14]. Available from: https://www.surgeongeneral.gov/priorities/prevention/strategy/report.pdf
   Google Scholar
• Los Angeles County Department of Public Health. How social and economic factors affect health. Los Angeles (CA): Department of Public Health; 2013 [cited 2017 Oct 14]. Available from: http://publichealth.lacounty.gov/epi/docs/SocialD_Final_Web.pdf
   Google Scholar
• Pedrana L, Pamponet M, Walker R, et al. Scoping review: national monitoring frameworks for social determinants of health and health equity. Glob Health Action. 2016;9(1):28831.
   PubMed Web of Science ®Google Scholar
• Health Policy Institute of Ohio. Making the most of community health planning in Ohio: the role of hospitals and local health departments. Columbus (OH): Health Policy Institute; 2015 [cited 2017 Oct 14]. Available from: http://www.healthpolicyohio.org/making-the-most-of-community-health-planning/
   Google Scholar
• Thomas SB, Quinn SC, Butler J, et al. Toward a fourth generation of disparities research to achieve health equity. Annu Rev Public Health. 2011;32:399–416.
   PubMed Web of Science ®Google Scholar
• Chin MH, Clarke AR, Nocon RS, et al. A roadmap and best practices for organizations to reduce racial and ethnic disparities in health care. J Gen Intern Med. 2012;27(8):992–1000.
   PubMed Web of Science ®Google Scholar
• Wilson L. Finding answers: disparities research for change progress report. Princeton (NJ): Robert Wood Johnson Foundation; 2013. [cited 2017 Oct 14]. Available from: http://www.rwjf.org/en/library/research/2013/10/finding-answers–disparities-research-for-change.html
   Google Scholar
• Horvat L, Horey D, Romios P, et al. Cultural competence education for health professionals. Cochrane Database Syst Rev. 2014;5:CD009405.
   Google Scholar
• Taylor LA, Tan AX, Coyle CE, et al. Leveraging the social determinants of health: what works? PLoS ONE. 2016;11(8):e0160217.
   PubMed Web of Science ®Google Scholar
• Cockerham WC, Hamby BW, Oates GR. The social determinants of chronic disease. Am J Prev Med. 2017;52(1 Suppl 1):S5–S12.
   PubMed Web of Science ®Google Scholar
• Ogbolu Y, Ford J, Cohn E, et al. Nurses on the move: Robert Wood Johnson Foundation nurse faculty scholars and their action on the social determinants of health. Ethn Health. 2017;11:1–11.
   Google Scholar
• Magnée T, Burdorf A, Brug J, et al. Equity-specific effects of 26 Dutch obesity-related lifestyle interventions. Am J Prev Med. 2013;44(6):e61–e70.
   Web of Science ®Google Scholar
• Lowrie R, McConnachie A, Williamson AE, et al. Incentivized chronic disease management and the inverse equity hypothesis: findings from a longitudinal analysis of Scottish primary care practice-level data. BMC Med. 2017;15:77.
   PubMed Web of Science ®Google Scholar
• Sequist TD. Health information technology and disparities in quality of care. J Gen Intern Med. 2011;26(10):1084–1085.
   PubMed Web of Science ®Google Scholar
• Scribner RA, Simonsen NR, Leonardi C. The social determinants of health core: taking a place-based approach. Am J Prev Med. 2017;52(1,Suppl1):S13–S19.
   PubMed Web of Science ®Google Scholar
• Institute of Medicine, Committee on Monitoring Access to Personal Health Care Services, Millman M, editor. Access to health care in America. Washington (DC): National Academies Press; 1993.
   Google Scholar
• Healthy People 2020. Access to Health Services. Washington (DC): U.S. Department of Health and Human Services; 2017 [cited 2017 Oct 13]. Available from: https://www.healthypeople.gov/2020/topics-objectives/topic/Access-to-Health-Services
   Google Scholar
• Hassan A, Scherer EA, Pikcilingis A, et al. Improving social determinants of health: effectiveness of a web-based intervention. Am J Prev Med. 2015;49(6):822–831.
   PubMed Web of Science ®Google Scholar
• Smith MD, Institute of Medicine (US). Committee on the learning health care system in America. Best care at lower cost: the path to continuously learning health care in America. Washington (DC): National Academies Press; 2013 [cited 2017 Oct 14]. Available from: https://www.nap.edu/catalog/13444/best-care-at-lower-cost-the-path-to-continuously-learning
   Google Scholar
• Ayanian JZ, Markel H. Donabedian’s lasting framework for health care quality. N Engl J Med. 2016;375(3):205–207.
   PubMed Web of Science ®Google Scholar
• On behalf of the American Heart Association Council on Quality of Care and Outcomes Research; Council on Cardiovascular Disease in the Young; Council on Clinical Cardiology; Council on Functional Genomics and Translational Biology; and Stroke Council, Maddox TM, Alpert NM, Borden WB, et al. The learning healthcare system and cardiovascular care: a scientific statement from the American Heart Association. Circulation 2017;135(14):e826–e857.
   PubMed Web of Science ®Google Scholar
• Centers for disease control and prevention. Leading causes of death and numbers of deaths, by sex, race, and Hispanic origin: United States, 1980 and 2014 (Table 19). Health, United States, 2015 [Updated 2017 Jun]. https://www.cdc.gov/nchs/data/hus/hus15.pdf#019
   Google Scholar
• Ward BW, Schiller JS, Goodman RA. Multiple chronic conditions among US adults: A 2012 update. Prev Chronic Dis. 2014;11:E62.
   PubMed Web of Science ®Google Scholar
• Robert Wood Johnson Foundation, Johns Hopkins Bloomberg School of Public Health. Chronic care: making the case for ongoing care. 2010 Feb, [cited 2017 Oct 8]. Available from: https://www.rwjf.org/content/dam/farm/reports/reports/2010/rwjf54583
   Google Scholar
• Heidenreich PA, Trogdon JG, Khavjou OA, et al. Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. Circulation. 2011;123(8):933–944.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control & Prevention, National Center for Health Statistics. Underlying cause of death 1999-2013 on CDC WONDER Online Database, released 2015. Data are from the multiple cause of death files, 1999-2013, as compiled from data provided by the 57 vital statistics jurisdictions through the Vital Statistics Cooperative Program. [cited 2017 Oct 8]. Available from: https://wonder.cdc.gov/ucd-icd10.html
   Google Scholar
• Sidney S, Quesenberry CP Jr, Jaffe MG, et al. Recent trends in cardiovascular mortality in the United States and public health goals. JAMA Cardiol. 2016;1(5):594–599.
   PubMed Web of Science ®Google Scholar
• Lloyd-Jones DM. Slowing progress in cardiovascular mortality rates: you reap what you sow. JAMA Cardiol. 2016;1(5):599–600.
   PubMed Web of Science ®Google Scholar
• Lyall DM, Celis-Morales C, Ward J, et al. Association of body mass index with cardiometabolic disease in the UK Biobank: A Mendelian randomization study. JAMA Cardiol. 2017;2(8):882–889.
   PubMed Web of Science ®Google Scholar
• Anyanwagu U, Mamza J, Donnelly R, et al. Effects of obesity on metabolic and cardiovascular outcomes following insulin initiation in patients with type 2 diabetes. Obes Res Clin Pract. 2017. Published before print. pii:S1871-403X(17)30081-9. DOI:10.1016/j.orcp.2017.08.005.
   PubMedGoogle Scholar
• Eckel RH, Kahn R, Robertson RM, et al. Preventing cardiovascular disease and diabetes. a call to action from the American Diabetes Association and the American Heart Association. Circulation. 2006;113(25):2943–2946.
   PubMed Web of Science ®Google Scholar
• On behalf of the American Heart Association Statistics Committee and Stroke Statistics Subcommittee, Benjamin EJ, Blaha MJ, Chiuve SE, et al. Heart disease and stroke statistics—2017 update: a report from the American Heart Association. Circulation 2017;135(10):e146–e603.
   PubMed Web of Science ®Google Scholar
• Sanchis-Gomar F, Perez-Quili C, Leischik R, et al. Epidemiology of coronary heart disease and acute coronary syndrome. Ann Transl Med. 2016;4(13):256.
   PubMed Web of Science ®Google Scholar
• Lippi G, Cervellin G. The interplay between genetics, epigenetics and environment in modulating the risk of coronary heart disease. Ann Transl Med. 2016;4(23):460.
   PubMed Web of Science ®Google Scholar
• Khera AV, Emdin CA, Drake I, et al. Genetic risk, adherence to a healthy lifestyle, and coronary disease. N Engl J Med. 2016;375:2349–2358.
   PubMed Web of Science ®Google Scholar
• Knapper JT, Ghasemzadeh N, Khayata M, et al. Time to change our focus defining, promoting, and impacting cardiovascular population health. J Am Coll Cardiol. 2015;66:960–971.
   PubMed Web of Science ®Google Scholar
• Wh L, Zhang H, Zhang YT. Investigation on cardiovascular risk prediction using physiological parameters. Comput Math Methods Med. 2013(2013):21. Article ID 272691. DOI:10.1155/2013/272691
   Google Scholar
• Stone NJ, Robinson JG, Lichtenstein AH, et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines. Circulation. 2014;129(25 Suppl 2):S1–S45.
   PubMed Web of Science ®Google Scholar
• Polonsky TS, Ning H, Daviglus ML, et al. Association of cardiovascular health with subclinical disease and incident events: the multi-ethnic study of atherosclerosis. J Amer Heart Assoc. 2017;6:e004894.
   PubMed Web of Science ®Google Scholar
• Fernández-Friera L, Peñalvo JL, Fernández-Ortiz A, et al. Prevalence, vascular distribution and multi-territorial extent of subclinical atherosclerosis in a middle-aged cohort: the PESA (Progression of Early Subclinical Atherosclerosis) Study. Circulation. 2015;131(24):2104–2113.
   PubMed Web of Science ®Google Scholar
• Uzhova I, Fuster V, Fernández-Ortiz A, et al. The importance of breakfast in atherosclerosis disease. insights from the PESA study. J Am Coll Cardiol. 2017;70(15):1833–1842.
   PubMed Web of Science ®Google Scholar
• Baber U, Mehran R, Sartori S, et al. Prevalence, impact, and predictive value of detecting subclinical coronary and carotid atherosclerosis in asymptomatic adults. The Bioimage Study. J Am Coll Cardiol. 2015;65(11):1065–1074.
   PubMed Web of Science ®Google Scholar
• Sacco RL, Roth GA, Reddy KS, et al. The Heart of 25 by 25: achieving the goal of reducing global and regional premature deaths from cardiovascular diseases and stroke: a modeling study from the American Heart Association and World Heart Federation. Circulation. 2016;133(23):e674–e690.
   PubMed Web of Science ®Google Scholar
• Health, United States, 2016. Centers for Disease Control and Prevention. Hyattsville (MD): National Center for Health Statistics; 2017. Available from: https://www.cdc.gov/nchs/data/hus/hus16.pdf
   Google Scholar
• Centers for Disease Control & Prevention. Childhood obesity facts. 2016 [cited 2017 Oct 10]. Available from: https://www.cdc.gov/healthyschools/obesity/facts.htm
   Google Scholar
• Trust for America’s Health, the Robert Wood Johnson Foundation. State of Obesity 2016. Obesity Rates & Trends Overview. [cited 2017 Oct 9]. Available from: https://stateofobesity.org/obesity-rates-trends-overview/
   Google Scholar
• Hales CM, Carroll MD, Fryar CD, et al. Prevalence of obesity among adults and youth: United States, 2015–2016. NCHS data brief. Hyattsville (MD): National Center for Health Statistics; 2017. p. 288. [cited 2017 Oct 13]. Available from: https://www.cdc.gov/nchs/products/databriefs/db288.htm
   Google Scholar
• NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults. Lancet. 2017;390(10113):2627–2642. DOI:10.1016/S0140-6736(17)32129-3.
   PubMed Web of Science ®Google Scholar
• Geier AB, Foster GD, Womble LG, et al. The relationship between relative weight and school attendance among elementary schoolchildren. Obesity. 2007;15(8):2157–2161.
   PubMed Web of Science ®Google Scholar
• Wang Y, Wu Y, Wilson RF, et al. What childhood obesity prevention programmes work? A systematic review and meta-analysis. ‎Obes Rev. 2015;16(7):547–565.
   PubMed Web of Science ®Google Scholar
• Singh AS, Mulder C, Twisk JWR, et al. Tracking of childhood overweight into adulthood: a systematic review of the literature. Obesity Rev. 2008;9(5):474–488.
   PubMed Web of Science ®Google Scholar
• Evensen E, Wilsgaard T, Furberg AS, et al. Tracking of overweight and obesity from early childhood to adolescence in a population-based cohort – the Tromsø Study, Fit Futures. BMC Ped. 2016;16:64.
   PubMed Web of Science ®Google Scholar
• Boyle JP, Thompson TJ, Gregg EW, et al. Projection of the year 2050 burden of diabetes in the US adult population: dynamic modeling of incidence, mortality, and prediabetes prevalence. Popul Health Metr. 2010;8:29.
   PubMed Web of Science ®Google Scholar
• Wong ND, Zhao Y, Patel R, et al. Cardiovascular risk factor targets and cardiovascular disease event risk in diabetes: a pooling project of the atherosclerosis risk in communities study, multi-ethnic study of atherosclerosis, and Jackson Heart Study. Diabetes Care. 2016;39(5):668–676.
   PubMed Web of Science ®Google Scholar
• Fuster V. A first dilemma in cardiovascular medicine: adherence versus personalized therapy. J Am Coll Cardiol. 2014;64(10):1059–1060.
   PubMed Web of Science ®Google Scholar
• Newman JD, Schwartzbard AZ, Weintraub HS, et al. Primary prevention of cardiovascular disease in diabetes mellitus. J Am Coll Cardiol. 2017;70(7):883–893.
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. Standards of medical care in diabetes—2017. Diabetes Care. 2017;40(Suppl1):S1–S135.
   PubMedGoogle Scholar
• Kelly SJ, Ismail M. Stress and type 2 diabetes: a review of how stress contributes to the development of type 2 diabetes. Annu Rev Public Health. 2015;18(36):441–462.
   Google Scholar
• Laakso M. Cardiovascular disease in type 2 diabetes from population to man to mechanisms. Diabetes Care. 2010;33(2):442–449.
   PubMed Web of Science ®Google Scholar
• Meigs JB. Epidemiology of type 2 diabetes and cardiovascular disease: translation from population to prevention. Diabetes Care. 2010;33(8):1865–1871.
   PubMedGoogle Scholar
• Mann DL, Zipes DP, Libby P, et al. editors. Braunwald’s heart disease: a textbook of cardiovascular medicine.10th ed. Philadelphia (PA): Elsevier/Saunders; 2015.
   Google Scholar
• Fuster V, Harrington RA, Narula J, et al. editors. Hurst’s the heart. 14th ed. New York (NY)McGraw-Hill Professional2014
   Google Scholar
• McGuire DK, Marx N. Diabetes in cardiovascular disease: a companion to Braunwald’s heart disease. 1st ed. Philadlephia (PA): Elsevier; 2014.
   Google Scholar
• Holt RIG, Cockram C, Flyvberg A, et al. Textbook of diabetes. 5th ed. Hoboken (NJ): John Wiley & Sons; 2017.
   Google Scholar
• Patel SA, Ali MK, Narayan KM, et al. County-level variation in cardiovascular disease mortality in the United States in 2009-2013: comparative assessment of contributing factors. Am J Epidemiol. 2016;184(12):933–942.
   PubMed Web of Science ®Google Scholar
• Kones R. Molecular sources of residual cardiovascular risk, clinical signals, and innovative solutions: relationship with subclinical disease, undertreatment, and poor adherence: implications of new evidence upon optimizing cardiovascular patient outcomes. Vasc Health Risk Manag. 2013;9:617–670.
   PubMedGoogle Scholar
• Kones R. Recent advances in the management of chronic stable angina. I. Approach to the patient, diagnosis, pathophysiology, risk stratification, and gender disparities. Vasc Health Risk Manag. 2010;6:635–656.
   PubMedGoogle Scholar
• Kones R, Rumana U. Dyslipidemia, risk factors, and the prevention of cardiovascular disease in women. J Womens Health (Larchmt). 2013;22(5):402–403.
   PubMed Web of Science ®Google Scholar
• Garcia M, Mulvagh SL, Merz CN, et al. Cardiovascular disease in women: clinical perspectives. Circ Res. 2016;118(8):1273–1293.
   PubMed Web of Science ®Google Scholar
• Spatz ES, Beckman AL, Wang Y, et al. Geographic variation in trends and disparities in acute myocardial infarction hospitalization and mortality by income levels,1999-2013. JAMA Cardiol. 2016;1(3):255–265.
   PubMed Web of Science ®Google Scholar
• Gamboa CM, Colantonio LD, Brown TM, et al. Race-sex differences in statin use and low-density lipoprotein cholesterol control among people with diabetes mellitus in the reasons for geographic and racial differences in stroke study. J Am Heart Assoc. 2017 10;6(5).
   Web of Science ®Google Scholar
• Hernandez-Suarez DF, Osterman-Pla AD, Carrasquillo O, et al. Epidemiological profile of hispanics admitted with acute myocardial infarction in Puerto Rico: the experience of 2007, 2009 and 2011. J Clin Med Res. 2017;9(6):528–533.
   PubMedGoogle Scholar
• Mouton CP, Hayden M, Southerland JH. Cardiovascular health disparities in underserved populations. Prim Care. 2017;44(1):e37–e71.
   PubMed Web of Science ®Google Scholar
• Kones R. Is prevention a fantasy, or the future of medicine? A panoramic view of recent data, status, and direction in cardiovascular prevention. Ther Adv Cardiovasc Dis. 2011;5(1):61–81.
   PubMedGoogle Scholar
• Yancy CW, Wang TY, Ventura HO, et al. The coalition to reduce racial and ethnic disparities in cardiovascular disease outcomes (credo): why credo matters to cardiologists. J Am Coll Cardiol. 2011;57:245–252.
   PubMed Web of Science ®Google Scholar
• Harold JG, Williams KA Sr. Disparities in cardiovascular care. Finding ways to narrow the gap. J Am Coll Cardiol. 2013;62(6):563–565.
   PubMed Web of Science ®Google Scholar
• Roth GA, Dwyer-Lindgren L, Bertozzi-Villa A, et al. Trends and patterns of geographic variation in cardiovascular mortality among US counties, 1980-2014. JAMA. 2017;317(19):1976–1992.
   PubMed Web of Science ®Google Scholar
• Mozaffarian D, Afshin A, Benowitz NL, et al.; on behalf of the American Heart Association Council on Epidemiology and Prevention, Council on Nutrition, Physical Activity and Metabolism, Council on Clinical Cardiology, Council on Cardiovascular Disease in the Young, Council on the Kidney in Cardiovascular Disease, Council on Peripheral Vascular Disease, American Heart Association Advocacy Coordinating Committee. Population approaches to improve diet, physical activity, and smoking habits: a scientific statement from the American Heart Association. Circulation. 2012;126:1514–1563.
   PubMed Web of Science ®Google Scholar
• Merino J, Kones R, Ros E. [Effects of the Mediterranean Diet upon endothelial function.] Efeitos da dieta mediterrânea sobre a função endotelial. Chapter 25, Section I. Disfunção Endotelial e Síndromes Clínicas, in Endothelium and Cardiovascular Diseases, [Ros E., Libby P. Eds, Ed 2]. In: Da Luz PL, Laurindo FRM, Chagas ACP, editors. Endotélio & Doenças Cardio Vasculares. 2ª. Edição, Biologia Vascular e Síndromes Clínicas. Atheneu, Brazil: Springer; 2016. p. 383–413.
   Google Scholar
• Georgousopoulou EN, Mellor DD, Naumovski N, et al. MEDIS study group. Mediterranean lifestyle and cardiovascular disease prevention. Cardiovasc Diagn Ther. 2017;7(Suppl 1):S39–S47.
   PubMedGoogle Scholar
• Ros E, Martínez-González MA, Estruch R, et al. Mediterranean diet and cardiovascular health: teachings of the PREDIMED study. Adv Nutr. 2014;5(3):330S–336S.
   PubMed Web of Science ®Google Scholar
• Baker EA, Barnidge EK, Schootman M, et al. Adaptation of a modified DASH diet to a rural African American community setting. Am J Prev Med. 2016;51(6):967–974.
   PubMed Web of Science ®Google Scholar
• Yusuf S, Öunpuu S, Dans T, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case–control study. Lancet. 2004;364(9438):937–952.
   PubMed Web of Science ®Google Scholar
• Albus C. Psychosocial risk factors: time for action in the lifelong prevention of coronary heart disease. Eur J Prev Cardiol. 2017;24(13):1369–1370.
   PubMed Web of Science ®Google Scholar
• Tawakol A, Ishai A, Takx RAP, et al. Relation between resting amygdalar activity and cardiovascular events: a longitudinal and cohort study. Lancet. 2017;389(10071):834–845.
   PubMed Web of Science ®Google Scholar
• Blackburn EH, Epel ES. Telomeres and adversity: too toxic to ignore. Nature. 2012;490(7419):169–171.
   PubMed Web of Science ®Google Scholar
• Lavizzo-Mourey R, Dorn JM, Fulton JE, et al. Physical activity guidelines for Americans mid-course report: strategies to increase physical activity among youth. Washington (DC): Department of Health and Human Services; 2012 [cited 2017 Oct 14]. Available from: http://health.gov/paguidelines/midcourse/pag-mid-course-report-final.pdf
   Google Scholar
• Clarke TC, Norris T, Schiller JS. Early release of selected estimates based on data from the National Health Interview Survey, 2016. Atlanta (GA): Centers for Disease Control and Prevention. 2017 [cited 2017 Oct 6]. Available from: https://www.cdc.gov/nchs/nhis/releases/released201705.htm#TechNotes
   Google Scholar
• Durstenfeld MS, Ogedegbe O, Katz SD, et al. Racial and ethnic differences in heart failure readmissions and mortality in a large municipal healthcare system. JACC Heart Failure. 2016;4(11):885–893.
   PubMed Web of Science ®Google Scholar
• Ziaeian B, Heidenreich PA, Xu H, et al. Race/ethnic differences in outcomes among hospitalized medicare patients with heart failure and preserved ejection fraction. JACC Heart Fail. 2017;5(7):483–493.
   PubMed Web of Science ®Google Scholar
• Blumenthal RS, Gluckman TJ, Martin SS. Trends in the use of moderate-intensity to high-intensity statin and nonstatin lipid-lowering therapy: turning off the faucet is much more valuable than mopping up the floor. JAMA Cardiol. 2017;2(4):355–356.
   PubMed Web of Science ®Google Scholar
• Kones R, Rumana U. Current treatment of dyslipidaemia: a new paradigm for statin drug use and the need for additional therapies. Drugs (Springer). 2015;75(11):1187–1199.
   Google Scholar
• Steen DL, Khan I, Ansell D, et al. Retrospective examination of lipid-lowering treatment patterns in a real-world high-risk cohort in the UK in 2014: comparison with the National Institute for Health and Care Excellence (NICE) 2014 lipid modification guidelines. BMJ Open. 2017;7(2):e013255.
   PubMed Web of Science ®Google Scholar
• Ference BA, Ginsberg HN, Graham G, et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel. Eur Heart J. 2017;38(32):2459–2472.
   PubMed Web of Science ®Google Scholar
• Rosenson RS, Kent ST, Brown TM, et al. Underutilization of high-intensity statin therapy after hospitalization for coronary heart disease. J Am Coll Cardiol. 2015;65(3):270–277.
   PubMed Web of Science ®Google Scholar
• US Preventive Services Task Force. Statin use for the primary prevention of cardiovascular disease in adults. US Preventive Services Task Force recommendation statement. JAMA. 2016;316(19):1997–2007.
   PubMed Web of Science ®Google Scholar
• Phillips E, Saseen JJ. Current controversies with recent cholesterol treatment guidelines. J Pharm Pract. 2016;29(1):15–25.
   PubMedGoogle Scholar
• Golomb BA, Evans MA. Statin adverse effects: a review of the literature and evidence for a mitochondrial mechanism. Am J Cardiovasc Drugs. 2008;8:373–418.
   PubMed Web of Science ®Google Scholar
• Stamler J, Stamler R, Neaton JD, et al. Low risk-factor profile and long-term cardiovascular and noncardiovascular mortality and life expectancy: findings for 5 large cohorts of young adult and middle-aged men and women. JAMA. 1999;282(21):2012–2018.
   PubMed Web of Science ®Google Scholar
• Pursnani A, Massaro JM, D’Agostino RB, et al. Guideline-based statin eligibility, coronary artery calcification, and cardiovascular events. JAMA. 2015;314(2):134–141.
   PubMed Web of Science ®Google Scholar
• Pandya A, Sy S, Cho S, et al. Cost-effectiveness of 10-year risk thresholds for initiation of statin therapy for primary prevention of cardiovascular disease. JAMA. 2015;314(2):142–150.
   PubMed Web of Science ®Google Scholar
• Ziaeian B, Dinkler J, Guo Y, et al. The 2013 ACC/AHA cholesterol treatment guidelines: applicability to patients with diabetes. Curr Diab Rep. 2016;16(2):13.
   PubMed Web of Science ®Google Scholar
• Fox CS, Golden SH, Anderson C, et al. Update on prevention of cardiovascular disease in adults with type 2 diabetes mellitus in light of recent evidence: a scientific statement from the American Heart Association and the American Diabetes Association. Circulation. 2015;132(8):691–718.
   PubMed Web of Science ®Google Scholar
• Nayor M, Vasan RS. Recent update to the US cholesterol treatment guidelines a comparison with international guidelines. Circulation. 2016;133(18):1795–1806.
   PubMed Web of Science ®Google Scholar
• Finegold JA, Shun-Shin MJ, Cole GD, et al. Distribution of lifespan gain from primary prevention intervention. Open Heart. 2016;3(1):1–9.
   Google Scholar
• Kickbusch I, Pelikan JM, Apfel F, et al. Health literacy. The solid facts. Copenhagen, Denmark: WHO Regional Office for Europe; 2013 [cited 2017 Oct 12]. Available from: http://www.euro.who.int/__data/assets/pdf_file/0008/190655/e96854.pdf?ua=1
   Google Scholar
• Pagidipati NJ, Navar AM, Mulder H, et al. Comparison of recommended eligibility for primary prevention statin therapy based on the US Preventive Services Task Force recommendations vs the ACC/AHA guidelines. JAMA. 2017;317(15):1563–1567.
   PubMed Web of Science ®Google Scholar
• Pokharel Y, Tang F, Jones PG, et al. Adoption of the 2013 American College of Cardiology/American Heart Association cholesterol management guideline in cardiology practices nationwide. JAMA Cardiol. 2017 1;2(4):361–369.
   PubMed Web of Science ®Google Scholar
• Guzman-Castillo M, Ahmed R, Hawkins N, et al. The contribution of primary prevention medication and dietary change in coronary mortality reduction in England between 2000 and 2007: a modelling study. BMJ Open. 2015;5:1 e006070.
   PubMed Web of Science ®Google Scholar
• Fontana M, Asaria P, Moraldo M, et al. Patient-accessible tool for shared decision making in cardiovascular primary prevention: balancing longevity benefits against medication. Circulation. 2014;129(34):242539–242546.
   Google Scholar
• Hutchins R, Viera AJ, Sheridan SL, et al. Quantifying the utility of taking pills for cardiovascular prevention. Circ Cardiovasc Qual Outcomes. 2015;8(2):155–163.
   PubMed Web of Science ®Google Scholar
• Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353:487–497.
   PubMed Web of Science ®Google Scholar
• Bosworth HB, Granger BB, Mendys P, et al. Medication adherence: a call for action. Am Heart J. 2011;162(3):412–424.
   PubMed Web of Science ®Google Scholar
• Ferdinand KC, Senatore FF, Clayton-Jeter H, et al. Improving medication adherence in cardiometabolic disease: practical and regulatory implications. J Am Coll Cardiol. 2017;69(4):437–451.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Public health grand rounds. overcoming barriers to medication adherence for chronic diseases. [cited 2017 Oct 6]. Available from: https://www.cdc.gov/cdcgrandrounds/pdf/archives/2017/GR_02-21-2017.pdf
   Google Scholar
• Jörntén-Karlsson M, Pintat S, Molloy-Bland M, et al. Patient-centered interventions to improve adherence to statins: a narrative synthesis of systematically identified studies. Drugs. 2016;76(15):1447–1465.
   PubMed Web of Science ®Google Scholar
• Kones R. Primary prevention of coronary heart disease: integration of new data, evolving views, revised goals, and role of rosuvastatin in management. A comprehensive survey. Drug Des Devel Ther. 2011;5:325–380.
   PubMed Web of Science ®Google Scholar
• Davis AM, Taitel MS, Jiang J, et al. A national assessment of medication adherence to statins by the racial composition of neighborhoods. J Racial Ethn Health Disparities. 2017;4(3):462–471.
   PubMed Web of Science ®Google Scholar
• Garcia-Retamero R, Andrade A, Sharit J, et al. Is patients’ numeracy related to physical and mental health? Med Decis Making. 2015;35:501–511.
   PubMed Web of Science ®Google Scholar
• Goodfellow NA, Almomani BA, Hawwa AF, et al. What the newspapers say about medication adherence: a content analysis. BMC Public Health. 2013;13:909.
   PubMed Web of Science ®Google Scholar
• Benjamin RM. Medication adherence: helping patients take their medicines as directed. Public Health Rep. 2012;127(1):2–3.
   PubMed Web of Science ®Google Scholar
• Cardiovascular Health. Medication adherence. Action steps for public health practitioners. Washington (DC): U.S. Department of Health & Human Services; 2016 [cited 2017 Oct 12]. Available from: https://millionhearts.hhs.gov/files/Medication-Adherence-Action-Guide-for-PHPs.pdf
   Google Scholar
• Lloyd-Jones DM, Hong Y, Labarthe D, et al. Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association’s strategic impact goal through 2020 and beyond on behalf of the American Heart Association Strategic Planning Task Force and Statistics Committee. Circulation. 2010;121:586–613.
   PubMed Web of Science ®Google Scholar
• Labarthe DR, Goldstein LB, Antman EM, et al. Evidence-based policy making: assessment of the American Heart Association’s strategic policy portfolio: a policy statement from the American Heart Association. Circulation. 2016 3;133(18):e615–e653.
   PubMed Web of Science ®Google Scholar
• Babamoto KS, Sey KA, Camillerai AJ, et al. Improving diabetes care and health measures among hispanics using community health workers. Results from a randomized controlled trial. Health Educ Behav. 2009;36(1):113–126.
   PubMed Web of Science ®Google Scholar
• Anderson LM, Adeney KL, Shinn C, et al. Community coalition-driven interventions to reduce health disparities among racial and ethnic minority populations. Cochrane Database Syst Rev. 2015;15(6):CD009905.
   Google Scholar
• Barbero C, Gilchrist S, Schooley MW, et al. Appraising the evidence for public health policy components using the quality and impact of component evidence assessment. Glob Heart. 2015;10:3–11.
   PubMed Web of Science ®Google Scholar
• Kivelä K, Elo S, Kyngäs H, et al. The effects of health coaching on adult patients with chronic diseases: a systematic review. Patient Educ Couns. 2014;97(2):147–157.
   PubMed Web of Science ®Google Scholar
• Willard-Grace R, Chen EH, Hessler D, et al. Health coaching by medical assistants to improve control of diabetes, hypertension, and hyperlipidemia in low-income patients: a randomized controlled trial. Ann Fam Med. 2015;13(2):130–138.
   PubMed Web of Science ®Google Scholar
• Ammentorp J, Uhrenfeldt L, Angel F, et al. Can life coaching improve health outcomes? A systematic review of intervention studies. BMC Health Serv Res. 2013;13:428.
   PubMed Web of Science ®Google Scholar
• Palmer S, Whybrow A. Health coaching to facilitate the promotion of healthy behaviour and achievement of health-related goals. Int J Health Promot Educ. 2003;13:91–93.
   Google Scholar
• Wolever RQ, Eisenberg DM. What is health coaching anyway? Standards needed to enable rigorous research. Arch Intern Med. 2011;171(22):2017–2018.
   PubMedGoogle Scholar
• Kramer CK, Zinman B, Retnakaran R. Are metabolically healthy overweight and obesity benign conditions? A systematic review and meta-analysis. Ann Intern Med. 2013;159:758–769.
   PubMed Web of Science ®Google Scholar
• Buscemi S, Chiarello P, Buscemi C, et al. Characterization of metabolically healthy obese people and metabolically unhealthy normal-weight people in a general population cohort of the ABCD study. J Diabetes Res. 2017;2017:9294038. 10.1155/2017/9294038
   PubMedGoogle Scholar
• Chang Y, Kim BK, Yun KE, et al. Metabolically-healthy obesity (MHO) and coronary artery calcification. J Am Coll Cardiol. 2014;63(24):2679–2686.
   PubMed Web of Science ®Google Scholar
• Lassale C, Tzoulaki I, Moons KGM, et al. Separate and combined associations of obesity and metabolic health with coronary heart disease: a pan-European case-cohort analysis. Eur Heart J Epub. 2017 August 14. 10.1093/eurheartj/ehx448
   PubMed Web of Science ®Google Scholar
• Caleyachetty R, Thomas GN, Toulis KA, et al. Metabolically healthy obese and incident cardiovascular disease events among 3.5 million men and women. J Am Coll Cardiol. 2017;70(12):1429–1437.
   PubMed Web of Science ®Google Scholar
• Gregg EW, Sattar N, Ali MK. The changing face of diabetes complications. Lancet Diabetes Endocrinol. 2016;4(6):537–547.
   PubMed Web of Science ®Google Scholar
• Castelnuovo G, Pietrabissa G, Manzoni GM, et al. Chronic care management of globesity: promoting healthier lifestyles in traditional and mHealth based settings. Front Psychol. 2015;15(6):1557.
   Google Scholar
• Ruffault A, Czernichow S, Hagger MS, et al. The effects of mindfulness training on weight-loss and health-related behaviours in adults with overweight and obesity: a systematic review and meta-analysis. Obes Res Clin Pract. 2017;11(5S1):90–111.
   PubMedGoogle Scholar
• Bacon L, Aphramor L. Weight science: evaluating the evidence for a paradigm shift. Nutrition J. 2011;10:9.
   Web of Science ®Google Scholar
• Garvey WT, Mechanick JI, Brett EM, et al. American Association of Clinical Endocrinologists and American College of Endocrinology. Comprehensive clinical practice guidelines for medical care of patients with obesity. Endocr Prac. 2016;22(Suppl 3):1–203.
   PubMed Web of Science ®Google Scholar
• GBD 2015 Obesity Collaborators. Health effects of overweight and obesity in 195 countries over 25 years. N Engl J Med. 2017;377:13–27.
   PubMed Web of Science ®Google Scholar
• Palmeira L, Cunha M, Pinto-Gouveia J. Processes of change in quality of life, weight self-stigma, body mass index and emotional eating after an acceptance-, mindfulness- and compassion-based group intervention (Kg-Free) for women with overweight and obesity. J Health Psychol. 2017;112:107–116.
   Google Scholar
• Rogers JM, Ferrari M, Mosely K, et al. Mindfulness-based interventions for adults who are overweight or obese: a meta-analysis of physical and psychological health outcomes. Obes Rev. 2017;18(1):51–67.
   PubMed Web of Science ®Google Scholar
• Koskinen J, Magnussen CG, Sinaiko A, et al. Between childhood metabolic syndrome and adult risk for metabolic syndrome, type 2 diabetes mellitus and carotid intima media thickness: the International Childhood Cardiovascular Cohort Consortium. J Am Heart Assoc. 2017;6(8):e005632.
   PubMedGoogle Scholar
• Narayan KMV, Chan J, Mohan V. Early identification of type 2 diabetes. Policy should be aligned with health systems strengthening. Diabetes Care. 2011;34(1):244–246.
   PubMed Web of Science ®Google Scholar
• Walker RJ, Strom-Williams J, Egede LE. Influence of race, ethnicity and social determinants of health on diabetes outcomes. Am J Med Sci. 2016;351(4):366–373.
   PubMed Web of Science ®Google Scholar
• Barker LE, Kirtland KA, Gregg EW, et al. Geographic distribution of diagnosed diabetes in the U.S.: a diabetes belt. Am J Prev Med. 2011;40(4):434–439.
   PubMed Web of Science ®Google Scholar
• Wu Y, Ding Y, Tanaka Y, et al. Risk factors contributing to type 2 diabetes and recent advances in the treatment and prevention. Int J Med Sci. 2014;11(11):1185–1200.
   PubMed Web of Science ®Google Scholar
• Wylie-Rosett J, Herman WH, Goldberg RB. Lifestyle intervention to prevent diabetes: intensive and cost effective. Curr Opin Lipidol. 2006;17(1):37–44.
   PubMed Web of Science ®Google Scholar
• McNaughton D. ‘Diabesity’ down under: overweight and obesity as cultural signifiers for type 2 diabetes mellitus. Crit Public Health. 2013;23(3):274–288.
   PubMed Web of Science ®Google Scholar
• Adwan MA, Najjar YW. The relationship between demographic variables and diabetes self-management in diabetic patients in Amman City/Jordan. Glob J Health Sci. 2013;5(2):213–320.
   PubMedGoogle Scholar
• Seligman H, Jacobs E, López A, et al. Food insecurity and glycemic control among low-income patients with type 2 diabetes. Diabetes Care. 2012;35(2):233–248.
   PubMed Web of Science ®Google Scholar
• Cuesta-Briand B, Saggers S, McManus A. ‘You get the quickest and the cheapest stuff you can’: food security issues among low-income earners living with diabetes. Aust Med J. 2011;4(12):683–691.
   Google Scholar
• Campbell DJT, Ronksley PE, Manns BJ, et al. The association of Income with health behavior change and disease monitoring among patients with chronic disease. Plos One. 2014;9(4):1–8.
   Web of Science ®Google Scholar
• Gregg EW. The changing tides of the type 2 diabetes epidemic—smooth sailing or troubled waters ahead? Kelly West Award Lecture 2016. Diabetes Care. 2017;40(10):1289–1297.
   PubMed Web of Science ®Google Scholar
• American College of Cardiology/American Heart Association Task Force on Practice Guidelines, Obesity Expert Panel, 2013. Expert panel report: guidelines (2013) for the management of overweight and obesity in adults. Obesity (Silver Spring). 2014;22(Suppl. 2)):S41–S410.
   PubMedGoogle Scholar
• Franz MJ. Weight management: obesity to diabetes. Diabetes Spectr. 2017;30(3):149–153.
   PubMedGoogle Scholar
• Evert AB, Franz MJ. Why weight loss maintenance is difficult. Diabetes Spectr. 2017;30(3):153–156.
   PubMedGoogle Scholar
• Tuso P. Prediabetes and lifestyle modification: time to prevent a preventable disease. Perm J. 2014;18(3):88–93.
   PubMedGoogle Scholar
• Ley SH, Korat AV, Sun Q, et al. Contribution of the nurses’ health studies to uncovering risk factors for type 2 diabetes: diet, lifestyle, biomarkers, and genetics. Am J Public Health. 2016;106(9):1624–1630.
   PubMed Web of Science ®Google Scholar
• Knowler WC, Fowler SE, Hamman RF, et al. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet. 2009;374(9702):1677–1686.
   PubMed Web of Science ®Google Scholar
• Tuomilehto J, Lindstrom J, Eriksson J, et al. Finnish Diabetes Prevention Study Group. Prevention of type2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344:1343–1350.
   PubMed Web of Science ®Google Scholar
• Weber MB, Twombly JG, Narayan KMV, et al. Lifestyle interventions and the prevention and treatment of type 2 diabetes. Amer J Lifestyle Med. 2015;4(6):468–480.
   Google Scholar
• Ioannidis JP, Lau J. The impact of high-risk patients on the results of clinical trials. J Clin Epidemiol. 1997;50:1089–1098.
   PubMed Web of Science ®Google Scholar
• Kent DM, Rothwell PM, Ioannidis JP, et al. Assessing and reporting heterogeneity in treatment effects in clinical trials: a proposal. Trials. 2010;11:85.
   PubMed Web of Science ®Google Scholar
• Sussman JB, Kent DM, Nelson JP, et al. Improving diabetes prevention with benefit based tailored treatment: risk based reanalysis of Diabetes Prevention Program. BMJ. 2015;350:h454.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC). CDC Diabetes Prevention Recognition Program standards and operating procedures. 2015 [cited 2017 Oct 10]. Available from: http://www.cdc.gov/diabetes/prevention/pdf/dprp-standards.pdf
   Google Scholar
• Cradock K, OLaighin G, Finucane F, et al. Behaviour change techniques targeting both diet and physical activity in type 2 diabetes: a systematic review and meta-analysis. Int J Behav Nutr Phys Act. 2017;14(1):18.
   PubMedGoogle Scholar
• Johansen MY, MacDonald CS, Hansen KB, et al. Effect of an intensive lifestyle intervention on glycemic control in patients with type 2 diabetes: a randomized clinical trial. JAMA. 2017;318(7):637–646
   PubMed Web of Science ®Google Scholar
• Schellenberg ES, Dryden DM, Vandermeer B, et al. Lifestyle interventions for patients with and at risk for type 2 diabetes: a systematic review and meta-analysis. Ann Intern Med. 2013;159(8):543–551.
   PubMed Web of Science ®Google Scholar
• Yoon U, Kwok L, Magkidis A. Efficacy of lifestyle interventions in reducing diabetes incidence in patients with impaired glucose tolerance: a systematic review of randomized controlled trials. Metabolism. 2013;62(2):303–314.
   PubMed Web of Science ®Google Scholar
• Kones R, Rumana U, Merino J. Exclusion of ‘nonRCT evidence’ in guidelines for chronic diseases – is it always appropriate? The Look AHEAD study. Curr Med Res Opin. 2014;30(10):2009–2019.
   PubMed Web of Science ®Google Scholar
• Eaglehouse YL, Kramer MK, Rockette-Wagner B, et al. Evaluation of physical activity reporting in community Diabetes Prevention Program lifestyle intervention efforts: a systematic review. Prev Med. 2015;77:191–199.
   PubMed Web of Science ®Google Scholar
• Diabetes Prevention Program Research Group. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study (DPPOS). Lancet. 2009;374(9702):1677–1686.
   PubMed Web of Science ®Google Scholar
• Look AHEAD Research Group. Eight-year weight losses with an intensive lifestyle intervention: the Look AHEAD study. Obesity (Silver Spring). 2014;1:5–13.
   Google Scholar
• Dunbar JA. Diabetes prevention in Australia: 10 years results and experience. Diabetes Metab. 2017;41:e3.
   Web of Science ®Google Scholar
• Nemah HH, Siebert Kuhlmann AK, Tabak RG. Effectiveness of program modification strategies of the Diabetes Prevention Program: a systematic review. Diabetes Educ. 2016;42(2):153–165.
   PubMed Web of Science ®Google Scholar
• Tabak RG, Sinclair KA, Baumann AA, et al. A review of diabetes prevention program translations: use of cultural adaptation and implementation research. Transl Behav Med. 2015;5(4):401–414.
   PubMed Web of Science ®Google Scholar
• Damschroder LJ, Reardon CM, AuYoung M, et al. Implementation findings from a hybrid III implementation-effectiveness trial of the Diabetes Prevention Program (DPP) in the Veterans Health Administration (VHA). Implement Sci. 2017;12(1):94.
   PubMedGoogle Scholar
• Hall DL, Lattie EG, McCalla JR, et al. Translation of the Diabetes Prevention Program to ethnic communities in the United States. J Immigr Minor Health. 2016;18(2):479–489.
   PubMed Web of Science ®Google Scholar
• Eaglehouse YL, Rockette-Wagner B, Kramer MK, et al. Physical activity levels in a community lifestyle intervention: a randomized trial. J Am Coll Sports Med. 2016;1(5):45–51.
   Google Scholar
• Knickman J, Hunt K. Good and bad news for diabetes prevention in the community. The Health Affairs Blog. 2015 [cited 2017 Oct 11]. Available from: http://healthaffairs.org/blog/2015/03/25/good-and-bad-news-for-diabetes-prevention-in-the-community/
   Google Scholar
• Aziz Z, Absetz P, Oldroyd J, et al. A systematic review of real-world diabetes prevention programs: learnings from the last 15 years. Implement Sci. 2015;10:172.
   PubMed Web of Science ®Google Scholar
• Ely EK, Gruss SM, Luman ET, et al. A national effort to prevent type 2 diabetes: participant-level evaluation of CDC’s National Diabetes Prevention Program. Diabetes Care. 2017;40(10):1331–1341.
   PubMed Web of Science ®Google Scholar
• Dyrstad SM, Hansen BH, Holme IM, et al. Comparison of self-reported versus accelerometer-measured physical activity. Med Sci Sports Exer. 2014;46(1):99–106.
   PubMed Web of Science ®Google Scholar
• Ackermann RT. From programs to policy and back again: the push and pull of realizing type 2 diabetes prevention on a national scale. Diabetes Care. 2017;40(10):1298–1301.
   PubMed Web of Science ®Google Scholar
• Avelere Health. Estimated federal impact of H.R. 962/S.452 “The Medicare Diabetes Prevention Act. Washington (DC): Avelere; 2014 [cited 2017 Oct 11]. Available from: http://www.diabetes.org/assets/pdfs/advocacy/estimated-federal-impact-of.pdf
   Google Scholar
• Institute for Clinical and Economic Review. Technology assessment forum. Diabetes prevention programs: effectiveness and value. Boston (MA): ICER; 2016 May [cited 2017 Oct 11]. Available from: https://icer-review.org/announcements/final-report-dpp/
   Google Scholar
• Centers for Disease Control and Prevention. National Diabetes Statistics Report. Estimates of diabetes and its burden in the United States. Atlanta (GA): Division of Diabetes Translation; 2017 [cited 2017 Oct 11]. Available from: https://www.cdc.gov/diabetes/pdfs/data/statistics/national-diabetes-statistics-report.pdf
   Google Scholar
• Dunkley AJ, Bodicoat DH, Greaves CJ, et al. Diabetes prevention in the real world: effectiveness of pragmatic lifestyle interventions for the prevention of type 2 diabetes and of the impact of adherence to guideline recommendations: a systematic review and meta-analysis. Diabetes Care. 2014;37(4):922–933.
   PubMed Web of Science ®Google Scholar
• Kahn R, Davidson MB. The reality of type 2 diabetes prevention. Diabetes Care. 2014;37(4):943–949.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Lifestyle coach facilitation guide. Core. Session 3: three ways to eat less fat and fewer calories. Atlanta (GA): CDC; 2017 [cited 2017 Oct 11]. Available from: https://www.cdc.gov/diabetes/prevention/pdf/curriculum_session3.pdf
   Google Scholar
• Rehm CD, Marquez ME, Spurrell-Huss E, et al. Lessons from launching the Diabetes Prevention Program in a large integrated health care delivery system: a case study. Popul Health Manag. 2017;20(4):262–270.
   PubMed Web of Science ®Google Scholar
• Barry E, Roberts S, Oke J, et al. Efficacy and effectiveness of screen and treat policies in prevention of type 2 diabetes: systematic review and meta-analysis of screening tests and interventions. BMJ. 2017;356:i6538.
   PubMed Web of Science ®Google Scholar
• Waugh N. Screen and intervene to prevent diabetes? BMJ. 2017 Apr 1;356:i6800.
   PubMedGoogle Scholar
• Khoury MJ The shift from personalized medicine to precision medicine and precision public health: words matter! 2016 April 21. [cited 2017 Oct 14]. Available from https://blogs.cdc.gov/genomics/2016/04/21/shift/
   Google Scholar
• Collins FS, Varmus H. A new initiative on precision medicine. N Engl J Med. 2015;372:793–795.
   PubMed Web of Science ®Google Scholar
• National Research Council (US) Committee on A Framework for Developing a New Taxonomy of Disease. Toward precision medicine: building a knowledge network for biomedical research and a new taxonomy of disease. Consensus Study Report. Washington (DC):National Academies Press; 2011. [cited 2017 Oct 11]. Available from: https://www.nap.edu/catalog/13284/toward-precision-medicine-building-a-knowledge-network-for-biomedical-research
   Google Scholar
• Schmidt C. Leroy Hood looks forward to P4 medicine: predictive, personalized, preventive, and participatory. J Natl Cancer Inst. 2014;106(12):1–2.
   Google Scholar
• Auffray C, Hood L. Systems biology and personalized medicine - the future is now. Biotechnol J. 2012;7(8):938–939.
   PubMed Web of Science ®Google Scholar
• Hood L, Balling R, Auffray C. Revolutionizing medicine in the 21st century through systems approaches. Biotechnol J. 2012;7(8):992–1001.
   PubMed Web of Science ®Google Scholar
• Adams SA, Petersen C. Precision medicine: opportunities, possibilities, and challenges for patients and providers. ‎J Am Med Inform Assoc. 2016;23(4):787–790.
   PubMed Web of Science ®Google Scholar
• Kashyap MV, Nolan M, Sprouse M, et al. Role of genomics in eliminating health disparities. J Carcinog. 2015;14:6.
   PubMedGoogle Scholar
• Bayer R, Galea S. Public health in the precision-medicine era. N Engl J Med. 2015 6. 373(6):499–501.
   PubMed Web of Science ®Google Scholar
• Khera AV, Kathiresan S. Genetics of coronary artery disease: discovery, biology and clinical translation. Nat Rev Genet. 2017;18(6):331–344.
   PubMed Web of Science ®Google Scholar
• Dzau VJ, Gindburg GS, Van Nuys K, et al. Aligning incentives to fulfil the promise of personalised medicine. Lancet. 2015;385(9982):2118–2119.
   PubMed Web of Science ®Google Scholar
• Khera AV, Mehta NN. Genetic variants at chromosome 9p21 and risk of first vs. subsequent coronary heart disease events. CardioSource, April 16, 2015 [cited 2017 Oct 14]. Available from: http://www.acc.org/latest-in-cardiology/articles/2015/04/16/07/57/genetic-variants-at-chromosome-9p21-and-risk-of-first-versus-subsequent-coronary-heart-disease-events
   Google Scholar
• Joyner MJ, Paneth N. Seven questions for personalized medicine. JAMA. 2015;314(10):999–1000.
   PubMed Web of Science ®Google Scholar
• Visscher PM, Brown MA, McCarthy MI, et al. Five years of GWAS discovery. Am J Hum Genet. 2012;90(1):7–24.
   PubMed Web of Science ®Google Scholar
• Hey SP, Kesselheim AS. Countering imprecision in precision medicine. Science. 2016 Jul 29;353(6298):448–449.
   PubMed Web of Science ®Google Scholar
• Mills JR. Precision medicine—right treatment, right patient, right time, wrong approach? Clin Chem. 2017;63:928–929.
   PubMed Web of Science ®Google Scholar
• Reddy SS. Evolving to personalized medicine for type 2 diabetes. Endocrinol Metab Clin North Am. 2016;45(4):1011–1020.
   PubMed Web of Science ®Google Scholar
• Buzzetti R, Prudente S, Copetti M, et al. Clinical worthlessness of genetic prediction of common forms of diabetes mellitus and related chronic complications: a position statement of the Italian Society of Diabetology. Nutr Metab Cardiovasc Dis. 2017;27(2):99–114.
   PubMed Web of Science ®Google Scholar
• Mozaffarian D. Global scourge of cardiovascular disease. Time for health care systems reform and precision population health. J Am Coll Cardiol. 2017;70(1):26–28.
   PubMed Web of Science ®Google Scholar
• Wing JJ, August E, Adar SD, et al. Change in neighborhood characteristics and change in coronary artery calcium. Circulation. 2016;134:504–513.
   PubMed Web of Science ®Google Scholar
• Roy B, Riley C. Moving into the neighborhood: thinking beyond individuals to improve cardiovascular health. Circ Cardiovasc Qual Outcomes. 2014;7(4):505–507.
   PubMed Web of Science ®Google Scholar
• Gómez-Pardo E, Fernández-Alvira J, Vilanova M, et al. A comprehensive lifestyle peer group-based intervention on cardiovascular risk factors: the randomized controlled Fifty-Fifty Program. J Am Coll Cardiol. 2016;67(5):476–485.
   PubMed Web of Science ®Google Scholar
• Shah RV, Murthy VL, Colangelo LA, et al. Association of fitness in young adulthood with survival and cardiovascular risk: the coronary artery risk development in young adults (CARDIA) study. JAMA Int Med. 2016;176(1):87–95.
   PubMed Web of Science ®Google Scholar
• Pulkki-Råback L, Elovainio M, Hakulinen C, et al. Cumulative effect of psychosocial factors in youth on ideal cardiovascular health in adulthood: the cardiovascular risk in young Finns study. Circulation. 2015;131(3):245–253.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. CDC health disparities and inequalities report – United States, 2013. MMWR. 2013;62(Suppl3):1–189. https://www.cdc.gov/minorityhealth/chdireport.html
   PubMedGoogle Scholar
• Satcher D, Higginbotham EJ. The public health approach to eliminating disparities in health. Am J Public Health. 2008;98(3):400–403.
   PubMed Web of Science ®Google Scholar
• Katz DL, Meller S. Can we say what diet is best for health? Annu Rev Public Health. 2014;35:83–103.
   PubMed Web of Science ®Google Scholar
• Kones R, Rumana U. Cardiometabolic diseases of civilization: history and maturation of an evolving global threat. An update and call for action. Ann Med (Taylor & Francis). 2017;49(3):260–274.
   Google Scholar
• Ning H, Labarthe DR, Shary CM, et al. Status of cardiovascular health in US children up to 11 years of age: the National Health and Nutrition Examination Surveys 2003–2010. Circ Cardiovasc Qual Outcomes. 2015;8(2):164–171.
   PubMed Web of Science ®Google Scholar
• Gooding HC, Shay CM, Ning H, et al. Optimal lifestyle components in young adulthood are associated with maintaining the ideal cardiovascular health profile into middle age. J Am Heart Assoc. 2015;4(11):e002048.
   PubMed Web of Science ®Google Scholar